All Stories

  1. Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma
  2. Early seizures and temporal lobe trauma predict post-traumatic epilepsy: A longitudinal study
  3. The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol
  4. Metabolic patterns and seizure outcomes following anterior temporal lobectomy
  5. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance
  6. Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs
  7. VDAC2 enables BAX to mediate apoptosis and limit tumor development
  8. Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide
  9. The role of interleukin‑6‑STAT3 signalling in glioblastoma (Review)
  10. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker
  11. First line direct access for transarterial embolization of a dural arteriovenous fistula: Case report and literature review
  12. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy
  13. Cancer exosomes in cerebrospinal fluid
  14. Post-operative seizure prophylaxis in gliomas
  15. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
  16. The emergent role of exosomes in glioma
  17. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin
  18. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab
  19. Postoperative seizure control in patients with tumor-associated epilepsy
  20. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit
  21. Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas
  22. Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib
  23. Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme
  24. MicroRNA as potential biomarkers in Glioblastoma
  25. Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma
  26. Large suprasellar mass: answer
  27. Large suprasellar mass: question
  28. Occult temporal lobe encephalocoele into the transverse sinus
  29. A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: Increasing glutamate uptake with PPARγ agonists
  30. In response: IDH1 mutation expression is associated with seizures and protoplasmic subtype in patients with low‐grade glioma
  31. The Continuing Evolution
  32. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low‐grade gliomas
  33. Complexities of lysophospholipid signalling in glioblastoma
  34. Tumour associated epilepsy and glutamate excitotoxicity in patients with gliomas
  35. Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging
  36. Implementing evidence-based recommended practices for the management of patients with mild traumatic brain injuries in Australian emergency care departments: study protocol for a cluster randomised controlled trial
  37. Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study
  38. Resective Surgery of Temporal Lobe Epilepsy
  39. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas
  40. Glutamate is associated with a higher risk of seizures in patients with gliomas
  41. Carcinoma of the paranasal sinuses
  42. Acoustic neurinoma (vestibular schwannoma)
  43. Epilepsy associated with brain tumors
  44. Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells
  45. An unusual cause of skull and cervical spine masses
  46. Spontaneous spinal epidural haematoma in a geriatric patient on aspirin
  47. Spinal cord compression as the initial presentation of acute biphenotypic leukaemia
  48. Surgery for Convexity Meningiomas
  49. SURGERY FOR EXTRA-AXIAL TUMORS OF THE CEREBRAL CONVEXITY AND MIDLINE
  50. SURGERY FOR EXTRA‐AXIAL TUMORS OF THE CEREBRAL CONVEXITY AND MIDLINE
  51. Diffuse choroid plexus hyperplasia: an under-diagnosed cause of hydrocephalus in children?
  52. Targeted therapy for malignant gliomas
  53. Idiopathic spinal cord herniation
  54. Epidemiology and Aetiological Factors